Congrats to Dr. John Quinlan who received the Humanism in Neurology award from the American Brain Foundation (ABF) Wednesday, April 21, during the organization’s virtual annual Commitment to Cures gala at the American Academy of Neurology annual meeting!

Fourth-year medical students selected John Quinlan, MD, professor and chief of the Neuromuscular Disorders Division, Department of Neurology and Rehabilitation Medicine as a 2021 recipients of the Silver Apple Award for clinical teaching!

The Office of Clinical Research within UC Health, which coordinates more than 1,000 clinical trials led by College of Medicine faculty each year, will physically and administratively move to the college, tentatively scheduled to occur by July 1-uc.edu/news/articles/…

Don't ditch the tPA in stroke thrombectomy yet - Outcomes after stroke thrombectomy were not better with tissue plasminogen activator (tPA) withheld, according to the MR CLEAN-NO IV trial. files.constantcontact.com/3b3a815a701/fd…

Bringing stroke patients straight to the angiography suite of a hospital capable of endovascular therapy reduced hospital delays and improved care for people with suspected large vessel occlusions who were admitted within six hours of symptom onset files.constantcontact.com/3b3a815a701/63…

Researchers find a new treatment for rare muscular disease-University of Cincinnati researchers have found a newer, more effective treatment for the disease Pompe that could become the new standard of care for the rare condition. in.style.yahoo.com/researchers-tr…...

A new treatment for late-onset Pompe disease—avalglucosidase alfa—appears to provide patients with a second treatment option and possibly a better safety profile, researchers reported at the 2021 virtual AAN Annual Meeting uc.edu/news/articles/… journals.lww.com/neurotodayonli…

Jack Bushnell Hanna, a retired American zookeeper and a former director emeritus of the Columbus Zoo and Aquarium, was recently diagnosed with dementia and what is now believed to be Alzheimer's disease. soundcloud.com/user-676892638…

Doctors can often detect and treat early-stage melanoma, but when it advances, it is much tougher to fight and is fatal nearly half the time. A team of UC scientists is developing a therapy that when taken together can improve existing melanoma treatments. abc12.com/2021/05/11/new…

Jennifer Molano, MD has been named associate director of the Center for Improvement Science(CIS), a core of the Center for Clinical and Translational Science and Training. The CIS provides Team Science education, evaluation services and facilitates interprofessional collaboration

Donald Gilbert, MD has been named the new associate director of curriculum development for the Medical Scientist Training Program. He fills the position held previously by Kathryn Wikenheiser-Brokamp, MD, PhD, associate professor in the Dept of Pathology who decided to step down

RNA technology has been used successfully in the battle against COVID-19. Now, UC researchers are hoping similar technology can help fight some of the deadliest forms of brain cancer - wcpo.com/news/local-new…

UC scientists are conducting research that could bring hope to those diagnosed with brain cancer. wcpo.com/news/local-new…

A research team including Soma Sengupta, MD, PhD, Harold C. Schott Endowed Brain Tumor Molecular Therapeutics Chair in the Dept of Neurology and Rehabilitation Medicine, received a nearly $2 million grant to develop agents for personalized therapeutic treatment of glioblastoma.

Researchers are testing a new class of drug in the fight against deadly melanoma. Years of sun exposure or other UV light is a risk factor for melanoma, which can be deadly if not caught early-wqad.com/article/news/h…

There were more deaths from Alzheimer's and dementia during the pandemic. Why? In addition to a disproportionate and deadlier impact on seniors, the COVID-19 pandemic has also had another devastating impact - more deaths from Alzheimer's and dementia- wvxu.org/post/there-wer…

Experts estimate more than 6 million Americans are living with Alzheimer’s dementia. But a recent study, led by the University of Cincinnati, sheds new light on the disease and a highly debated new drug therapy- uc.edu/news/articles/…

In Memoriam: Charles Olinger, MD Charles Olinger, MD, an emeritus professor in the Department of Neurology and Rehabilitation Medicine, died July 23. He was 91. Olinger was a pioneer in multicenter studies anti-platelet drugs to reduce the risk of strokes.

Sunflower Rev It Up for Parkinson’s run, walk and bike event is Sept. 12 - sunflowerrev.org

UC Gardner Neuroscience Institute given another architectural design award - The UC Gardner Neuroscience Institute has been named as a recipient of a 2021 Healthcare Design Award from the American Institute of Architects Academy of Architecture for Health.